New Product: Mayzent (siponimod fumaric acid) 0.25 mg and 2mg film-coated tablets
electronic Medicines Compendium - eMC
electronic Medicines compendium
23 January 2020
Siponimod fumaric acid is licensed for treatment of adults with secondary progressive multiple sclerosis with active disease evidenced by relapses or imaging features of inflammatory activity.